← brief for 2026-10-08 · Slowing decline

Beyond the 4 pillars: aldosterone synthase inhibition as a fifth frontier in chronic kidney disease management.

Key takeaways

This is a review article that discusses a new type of blood pressure drug. It suggests these drugs could be a new way to manage kidney disease. The article talks about the idea, but it does not report new test results. It is a discussion of a potential future treatment.

Who did this work

Schlaich MP · Woodhams L · Herat LY · Bell DA

Source

Paper · PubMed, the drug frontier · 2026 Oct 1
https://pubmed.ncbi.nlm.nih.gov/42847218/